Search Results 1-10 of 14152 for anti-TNF drugs

  1. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD

    Approved in 1998 for use in treating Crohn's disease and subsequently in 2005 for treating ulcerative colitis, anti-tumor necrosis factor (TNF) agents have ...

  2. Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy - Mayo Clinic

    About this study. The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with ...

  3. Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

    Within the United States, four anti-TNF agents are currently approved for the treatment of IBD — infliximab, adalimumab, certolizumab pegol and golimumab.

  4. Etanercept (subcutaneous route) - Mayo Clinic

    Drug Interactions · Abatacept · Adalimumab · Adenovirus Vaccine Type 4, Live · Adenovirus Vaccine Type 7, Live · Anakinra · Anifrolumab-fnia · Bacillus of Calmette and ...

  5. Ulcerative Colitis Clinical Trials - Mayo Clinic Research

    ... medications such as the anti-Tumor Necrosis Factor (anti-TNF) agents infliximab, adalimumab, and certolizumab. However, many CD and UC patients still ...

  6. Adalimumab (subcutaneous route) - Mayo Clinic

    Psoriatic arthritis usually occurs with a skin condition called psoriasis. Adalimumab may be used alone or in combination with medicines (eg, methotrexate or ...

  7. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

    However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side effects of the anti-TNF agents include increased ...

  8. Crohn's Disease Clinical Trials

    The purpose of this study is to determine whether adding low dose methotrexate to anti -TNF therapy is more effective than treatment with anti-TNF therapy alone ...

  9. Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease - Mayo Clinic

    However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side effects of the anti-TNF agents include increased ...

  10. Treatment response and management of biologics in patients with ECD - Mayo Clinic

    These include tumor necrosis factor-alpha (TNFα) inhibitors (certolizumab, infliximab, adalimumab), anti-integrin agents (vedolizumab, natalizumab), and ...